CATALOGO DEI PRODOTTI DELLA RICERCA

MAURELLI, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.596
NA - Nord America 2.146
AS - Asia 1.795
SA - Sud America 247
AF - Africa 77
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.083
RU - Federazione Russa 1.258
SG - Singapore 732
CN - Cina 359
IT - Italia 256
HK - Hong Kong 216
GB - Regno Unito 213
BR - Brasile 208
DE - Germania 205
IE - Irlanda 150
FR - Francia 141
SE - Svezia 115
VN - Vietnam 104
FI - Finlandia 101
IN - India 75
KR - Corea 70
JP - Giappone 67
ID - Indonesia 46
NL - Olanda 34
CA - Canada 33
ES - Italia 29
SA - Arabia Saudita 27
TG - Togo 25
MX - Messico 20
TR - Turchia 20
BJ - Benin 19
AT - Austria 18
UA - Ucraina 18
AR - Argentina 17
BE - Belgio 12
IQ - Iraq 11
PL - Polonia 11
ZA - Sudafrica 9
AU - Australia 8
BD - Bangladesh 8
EG - Egitto 8
IR - Iran 8
EC - Ecuador 7
HU - Ungheria 7
IL - Israele 6
TW - Taiwan 6
KE - Kenya 5
MY - Malesia 5
CL - Cile 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
BG - Bulgaria 3
BH - Bahrain 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
GR - Grecia 3
LB - Libano 3
LK - Sri Lanka 3
LT - Lituania 3
MA - Marocco 3
PH - Filippine 3
UY - Uruguay 3
UZ - Uzbekistan 3
AG - Antigua e Barbuda 2
BN - Brunei Darussalam 2
CO - Colombia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
JO - Giordania 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PF - Polinesia Francese 1
PY - Paraguay 1
RW - Ruanda 1
SI - Slovenia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.876
Salva come PNG Salva come JPEG
Città #
Dallas 630
Moscow 438
Singapore 324
Chandler 244
Hong Kong 211
Ashburn 200
Dublin 138
Munich 110
Beijing 93
Southend 87
Helsinki 68
The Dalles 68
New York 64
Los Angeles 50
Ho Chi Minh City 48
London 43
Jacksonville 42
Verona 37
Lawrence 34
Princeton 34
Jakarta 30
Redondo Beach 30
Buffalo 28
Milan 28
Wilmington 28
Lomé 25
Paris 25
Amsterdam 23
São Paulo 21
Riyadh 20
Sindelfingen 20
Woodbridge 20
Cotonou 19
Chennai 18
Lappeenranta 18
Rome 18
Tokyo 18
Washington 18
Santa Clara 17
Jinan 16
Manchester 16
Monza 16
Seattle 16
Chicago 14
Hanoi 14
Madrid 14
Nuremberg 14
Houston 13
Mumbai 13
Bologna 12
Boston 12
Frankfurt am Main 12
Bethnal Green 11
Ghaziabad 11
Warsaw 11
Ann Arbor 10
Liverpool 10
Nanjing 10
Phoenix 10
Guangzhou 9
Montreal 9
Ankara 8
Brasília 8
Dongguan 8
Haiphong 8
Redwood City 8
San Jose 8
Shanghai 8
Tianjin 8
Vancouver 8
Atlanta 7
Bari 7
Chieri 7
Fairfield 7
Giza 7
Marseille 7
Mexico City 7
Orem 7
Wakabadai 7
Brussels 6
Budapest 6
Gurugram 6
Igusa 6
Jyväskylä 6
Minamimotomachi 6
Stockholm 6
Toronto 6
Vienna 6
Belo Horizonte 5
Brindisi 5
Brooklyn 5
Coquitlam 5
Hanover 5
Hyderabad 5
Konya 5
Miami 5
Redmond 5
Shenyang 5
Berlin 4
Bắc Ninh 4
Totale 3.907
Salva come PNG Salva come JPEG
Nome #
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 308
A systematic review of treatments for pityriasis lichenoides 295
Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective study 202
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study 157
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 152
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 152
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study 145
A case of genital primary syphilis with superimposed impetigo 143
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 143
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 137
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series 131
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 131
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis 130
Gender perspective in the management of psoriasis 126
Amicrobial Pustulosis of the Folds: Report of Three New Cases 123
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature 120
A man with a widespread bullous eruption 116
Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study 115
Adrenergic urticaria successfully treated with omalizumab 114
Annular Erythema: New and Revisited Variants 113
Advanced Glycation End Products and Psoriasis 112
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 108
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 107
Neutrophilic figurate erythema: report of a new case in an adult and comparison between adult and paediatric cases 106
Clinical profile and co-infections of urethritis in males 106
Biological agents targeting interleukin-13 for atopic dermatitis 104
Advanced Glycation End Products are Increased in the Skin and Blood of Patients with Severe Psoriasis 103
Price variability of TNF-α inhibitor biosimilars among European countries 97
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 96
Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder: A Case Series 93
Interferon-beta injection site reactions in patients with multiple sclerosis. 93
Milia-like calcinosis cutis in Down syndrome: a new case with a review of the literature 90
Idiopathic lichenoid and granulomatous dermatitis 90
Atopic Dermatitis in the Elderly Population 88
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 88
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 85
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo 84
Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients 83
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 82
null 80
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes 79
Uncommon Non‑Infectious Annular Dermatoses 79
Severe cutaneous aluminum reaction to quadrivalent human papillomavirus vaccine treated with cyclosporin 78
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 77
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients 75
Managing the Patient with Psoriasis and Metabolic Comorbidities 73
Visual Vignette 72
Eosinophilic annular erythema successfully treated with cyclosporine 71
Palisaded neutrophilic granulomatous dermatitis and its associations with autoimmune diseases 70
Long‑Term Effectiveness and Safety of Ixekizumab for the Treatment of moderate‑to‑Severe Plaque Psoriasis: A Five‑Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) 69
Safety and Efectiveness of Upadacitinib in Patients with Moderate‐to‐Severe Atopic Dermatitis Who Smoke: a 2‐Year Real‐Life Multicenter Study 69
Lichen planopilaris coexisting with plaque psoriasis effectively treated with brodalumab 69
The emerging role of the neuroimmune cytokine interleukin-31 in chronic inflammatory skin diseases 67
Variations of symptoms of atopic dermatitis and psoriasis in relation to menstrual cycle 66
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 65
Tailored biological treatment for patients with moderate-to-severe psoriasis 64
Pruritus as a Distinctive Feature of Type 2 Inflammation 63
Targeting IL-4 for the Treatment of Atopic Dermatitis 62
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 60
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 59
Long-term effectiveness and tolerability of apremilast in patients with moderate-to- severe plaque psoriasis: A 5-year multicentre retrospective study—IL PSO (Italian landscape psoriasis) 56
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience 55
Efcacy and safety of JAK inhibitors in patients aged >60 years with moderate‐to‐severe atopic dermatitis: a 52‐week multicenter, real‐life study—IL AD (Italian Landscape Atopic Dermatitis) 55
Lymphoplasmacytic plaque effectively treated with imiquimod 53
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 50
The Combination of Dupilumab with Other Monoclonal Antibodies 50
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 44
Overview of Atopic Dermatitis in Different Ethnic Groups 43
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study – il AD (Italian landscape atopic dermatitis 42
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 41
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260‐Week Real‐World Multicenter Retrospective Study Exploring the Role of Concomitant PsA–IL PSO (Italian Landscape Psoriasis) 40
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis 39
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study 26
Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations 16
Effectiveness and safety of upadacitinib in patients with moderate-to-severe atopic dermatitis and prior inefficacy of T helper 2 biologics: a propensity score-matched study 13
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis 8
The Girl with a Pearl Earring: A dermatological puzzle 7
Totale 6.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.161
article - articoli 25.729
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 432
Totale 52.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 16 10 1 6 2 13 10
2021/2022228 13 26 0 18 31 6 6 23 4 14 30 57
2022/2023738 38 68 63 134 58 187 16 34 90 13 25 12
2023/2024647 16 30 56 51 52 126 115 42 8 39 71 41
2024/20251.894 119 63 98 291 80 115 168 111 244 136 143 326
2025/20263.110 293 169 674 610 1.141 223 0 0 0 0 0 0
Totale 6.973